Extended Course of Paxlovid Adds No Benefit for Those With Long COVID
FRIDAY, June 7, 2024 (HealthDay News) — An extended course of the antiviral drug Paxlovid won’t ease a person’s Long COVID symptoms, a new study finds. People who took Paxlovid for 15 days — three times as long as it’s prescribed for an initial COVID infection — had no betterContinue Reading